(Q39367515)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203869%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203869%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

0 references

0 references

invasive aspergillosis

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203869%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Florian Prüller

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203869%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Martin Hoenigl

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203869%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Holger Flick

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203869%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Christoph Koidl

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203869%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Reinhard B Raggam

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203869%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Michael Palfner

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203869%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Susanne Eigl

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203869%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Walter Buzina

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203869%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Ines Zollner-Schwetz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203869%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Christopher R Thornton

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203869%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Robert Krause

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203869%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

language of work or name

English

0 references

publication date

1 October 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203869%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Respiratory and Critical Care Medicine

16 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203869%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

190

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203869%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203869%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

922-929

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203869%20AND%20SRC:MED&resulttype=core&format=json

Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies.

16 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Unusual forms of subacute invasive pulmonary aspergillosis in patients with solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Probable invasive aspergillosis without prespecified radiologic findings: proposal for inclusion of a new category of aspergillosis and implications for studying novel therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Long-term stability at -20 °C of Aspergillus galactomannan in serum and bronchoalveolar lavage specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Interlaboratory and interstudy reproducibility of a novel lateral-flow device and influence of antifungal therapy on detection of invasive pulmonary aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3)

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

The utility of bronchoalveolar lavage beta-D-glucan testing for the diagnosis of invasive fungal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Automation of serum (1→3)-beta-D-glucan testing allows reliable and rapid discrimination of patients with and without candidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Invasive pulmonary aspergillosis in acute exacerbation of chronic obstructive pulmonary disease and the diagnostic value of combined serological tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: an emerging fungal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Bronchogenic carcinoma and secondary aspergillosis--common yet unexplored: evaluation of the role of bronchoalveolar lavage-polymerase chain reaction and some nonvalidated serologic methods to establish early diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Systemic antifungal therapy in critically ill patients without invasive fungal infection*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Azole resistance in Aspergillus fumigatus: a growing public health concern.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Galactomannan in Bronchoalveolar Lavage Fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201407-1275OC

Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance

21 January 2018

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1086/422009

Identifiers

DOI

10.1164/RCCM.201407-1275OC

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203869%20AND%20SRC:MED&resulttype=core&format=json

release_dxydfv63jfbndig56wu2qd55vm

16 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dxydfv63jfbndig56wu2qd55vm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference